A healthcare provider may prescribe
dasatinib (
Sprycel®) to help treat a certain type of
leukemia called chronic myeloid leukemia (
CML). This medication is approved for use in adults age 18 and older.
CML is a slowly progressing leukemia in which bone marrow stem cells (the early cells that form blood cells) develop into many abnormal granulocytes (a type of white blood cell). Some of these cells never become mature white blood cells (also called blasts). Over time, the granulocytes and blasts crowd out the red blood cells and platelets in the bone marrow.
Dasatinib works to treat CML by reducing the activity of a certain type of protein in the body that the cancer cells need to grow.
HealthSavvy Sign In
|